The FDA's proposal would take semaglutide, tirzepatide, and liraglutide off the 503B production list permanently, which closes the factory-scale pipeline those businesses run on
For most people the real question is whether the patch itself creates meaningful weight loss, and the honest answer is that there is no strong clinical evidence that typical consumer patches deliver medication level effects through the skin
Berthoud predicts something similar will happen with VIBES
The FAE dimethyl fumarate (DMF) works at a number of levels, including blockage of signal transduction factors Nrf2, Nf-B, STAT1/STAT3, and HIF-1
Since weight loss is a primary treatment for IIH, and GLP-1 drugs promote weight loss, these medications are being studied as a possible treatment option for this condition
Its a passive change rather than an act of discipline, and that distinction matters enormously for long-term adherence